299 related articles for article (PubMed ID: 31847126)
1. O-GlcNAc Transferase Regulates Angiogenesis in Idiopathic Pulmonary Arterial Hypertension.
Barnes JW; Tian L; Krick S; Helton ES; Denson RS; Comhair SAA; Dweik RA
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847126
[TBL] [Abstract][Full Text] [Related]
2. O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.
Barnes JW; Tian L; Heresi GA; Farver CF; Asosingh K; Comhair SA; Aulak KS; Dweik RA
Circulation; 2015 Apr; 131(14):1260-8. PubMed ID: 25663381
[TBL] [Abstract][Full Text] [Related]
3. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis.
Vang S; Helton ES; Guo Y; Burpee B; Rose E; Easter M; Bollenbecker S; Hirsch MJ; Matthews EL; Jones LI; Howze PH; Rajasekaran V; Denson R; Cochran P; Attah IK; Olson H; Clair G; Melkani G; Krick S; Barnes JW
Front Immunol; 2024; 15():1387197. PubMed ID: 38665916
[TBL] [Abstract][Full Text] [Related]
5. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
6. Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro.
Yamamura A; Fujitomi E; Ohara N; Tsukamoto K; Sato M; Yamamura H
Eur J Pharmacol; 2017 Sep; 810():44-50. PubMed ID: 28603047
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells.
Donovan K; Alekseev O; Qi X; Cho W; Azizkhan-Clifford J
Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):7862-73. PubMed ID: 25352121
[TBL] [Abstract][Full Text] [Related]
8. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.
Angelova M; Ortiz-Meoz RF; Walker S; Knipe DM
J Virol; 2015 Aug; 89(16):8474-83. PubMed ID: 26041297
[TBL] [Abstract][Full Text] [Related]
10. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
Yamamura A; Nayeem MJ; Sato M
Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells.
Akella NM; Le Minh G; Ciraku L; Mukherjee A; Bacigalupa ZA; Mukhopadhyay D; Sodi VL; Reginato MJ
Mol Cancer Res; 2020 Apr; 18(4):585-598. PubMed ID: 31974291
[TBL] [Abstract][Full Text] [Related]
12.
Su C; Schwarz TL
J Neurosci; 2017 Feb; 37(8):2125-2136. PubMed ID: 28115479
[No Abstract] [Full Text] [Related]
13.
Guo H; Zhang B; Nairn AV; Nagy T; Moremen KW; Buckhaults P; Pierce M
J Biol Chem; 2017 Mar; 292(10):4123-4137. PubMed ID: 28096468
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
15. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
16. Capsaicin-induced Ca
Song S; Ayon RJ; Yamamura A; Yamamura H; Dash S; Babicheva A; Tang H; Sun X; Cordery AG; Khalpey Z; Black SM; Desai AA; Rischard F; McDermott KM; Garcia JG; Makino A; Yuan JX
Am J Physiol Lung Cell Mol Physiol; 2017 Mar; 312(3):L309-L325. PubMed ID: 27979859
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Inhibitors of O-GlcNAc Transferase That Act In Vivo Implicate Decreased O-GlcNAc Levels in Leptin-Mediated Nutrient Sensing.
Liu TW; Zandberg WF; Gloster TM; Deng L; Murray KD; Shan X; Vocadlo DJ
Angew Chem Int Ed Engl; 2018 Jun; 57(26):7644-7648. PubMed ID: 29756380
[TBL] [Abstract][Full Text] [Related]
18. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
19. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
Qi J; Wang R; Zeng Y; Yu W; Gu Y
Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
[TBL] [Abstract][Full Text] [Related]
20. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
